Dermatofibrosarcoma Protuberans in Children

被引:7
作者
Sleiwah, Aseel [1 ]
Wright, Thomas C. [1 ]
Chapman, Thomas [1 ]
Dangoor, Adam [2 ]
Maggiani, Francesca [1 ,3 ]
Clancy, Rachel [1 ]
机构
[1] Southmead Hosp, Dept Plast & Reconstruct Surg, Southmead Rd, Bristol BS10 5NB, Avon, England
[2] Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol Canc Inst, Bristol BS2 8ED, Avon, England
[3] Univ Bristol, Bristol BS8 1TH, Avon, England
关键词
Paediatric dermatofibrosarcoma; Dermatofibrosarcoma; Skin tumours; Soft tissue sarcoma; Cutaneous surgery; MOHS MICROGRAPHIC SURGERY; GIANT-CELL FIBROBLASTOMA; WIDE LOCAL EXCISION; IMATINIB MESYLATE; DIAGNOSIS; PATHOLOGY; TISSUE; SERIES; STI571; CD34;
D O I
10.1007/s11864-022-00979-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Opinion statement Paediatric dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue malignant tumour which displays aggressive local behaviour and has low metastatic potential. The diagnosis is often delayed as DFSP is usually mistaken for other skin conditions, particularly in the early stages of disease. DFSP tends to follow an indolent course after the initial presentation with what is often described as a "rubbery lump". As the disease progresses, the lump tends to enlarge, change colour, and exhibit a more nodular consistency. In rare cases, DFSP can present as an ulcerated exophytic lesion or a depressed area of skin, making diagnosis even more challenging. A high index of suspicion is warranted for early diagnosis, and referral to a specialist unit with expertise in both oncologic resection and reconstruction. DFSP tumours arise from the dermis and grow with finger-like projections. Therefore, in cosmetically sensitive or functionally important locations, an excision and analysis technique that assesses all excision margins is the gold standard of care. Slow Mohs technique performed with en bloc excision is a well-tolerated option for oncologic resection of the tumour. Mohs technique can also be considered but can be challenging in children for reasons explained below. As an alternative, depending on the anatomical location, tumours can be excised with a wide local excision. While an excision technique that incorporates the deep fascia with a 3-cm peripheral margin is acceptable in adults, planning of the excision margin in children should involve consideration of preoperative imaging with MRI, site of the tumour, age, and physical built of the child. Patients should be offered all treatment options considering the local outcomes, available expertise, and cost. A multidisciplinary approach and good communication between team members is crucial. Close collaboration with a pathologist who is familiar with sectioning technique that allows margin control is of paramount importance. Soft tissue reconstruction should be performed immediately after oncologic clearance, although a staged approach may be required. Adjuvant radiotherapy should be avoided in children due to the long-term risk of secondary malignancies and potential for growth disruption.
引用
收藏
页码:843 / 854
页数:12
相关论文
共 63 条
[1]   CD34 AND FACTOR-XIIIA IN THE DIFFERENTIAL-DIAGNOSIS OF DERMATOFIBROMA AND DERMATOFIBROSARCOMA PROTUBERANS [J].
ABENOZA, P ;
LILLEMOE, T .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1993, 15 (05) :429-434
[2]  
[Anonymous], 2021, NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Cancer
[3]  
Bowne WB, 2000, CANCER, V88, P2711
[4]   Mohs micrographic surgery for dermatofibrosarcoma protuberans in 7 patients aged 10 years and younger [J].
Brough, Kevin R. ;
Youssef, Molly J. ;
Winchester, Daniel S. ;
Baum, Christian L. ;
Sharaf, Basel A. ;
Roenigk, Randall K. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (06) :1429-1431
[5]   Dermatofibrosarcoma protuberans, fibrosarcomatous variant: A rare tumor in children [J].
Chicaud, Matthieu ;
Frassati-Biaggi, Annonciade ;
Kaltenbach, Sophie ;
Karanian, Marie ;
Orbach, Daniel ;
Fraitag, Sylvie .
PEDIATRIC DERMATOLOGY, 2021, 38 (01) :217-222
[6]   Radiotherapy in the treatment of dermatofibrosarcoma protuberans [J].
Dagan, R ;
Morris, CG ;
Zlotecki, RA ;
Scarborough, MT ;
Mendenhall, WM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06) :537-539
[7]  
Darier J, 1924, Ann Dermatol Venereol, V5, P545
[8]   Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance [J].
David, Marjorie Parker ;
Funderburg, Ashley ;
Selig, James P. ;
Brown, Rebecca ;
Caliskan, Pip M. ;
Cove, Lee ;
Dicker, Gayle ;
Hoffman, Lori ;
Horne, Tammi ;
Gardner, Jerad M. .
JAMA NETWORK OPEN, 2019, 2 (08) :E1910413
[9]   A 10-year review of surgical management of dermatofibrosarcoma protuberans [J].
Durack, A. ;
Gran, S. ;
Gardiner, M. D. ;
Jain, A. ;
Craythorne, E. ;
Proby, C. M. ;
Marsden, J. ;
Harwood, C. A. ;
Matin, R. N. .
BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (04) :731-739
[10]   Dermatofibrosarcoma Protuberans: How Wide Should We Resect? [J].
Farma, Jeffrey M. ;
Ammori, John B. ;
Zager, Jonathan S. ;
Marzban, Suroosh S. ;
Bui, Marilyn M. ;
Bichakjian, Christopher K. ;
Johnson, Timothy M. ;
Lowe, Lori ;
Sabel, Michael S. ;
Wong, Sandra L. ;
Letson, G. Douglas ;
Messina, Jane L. ;
Cimmino, Vincent M. ;
Sondak, Vernon K. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) :2112-2118